OncoSec: OncoSec Announces Reverse Stock Split
OncoSec Medical Incorporated (NASDAQ: ONCS), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune... Read MoreThe post OncoSec Announces Reverse Stock Split appeared first on citybiz.
Read full article »
OncoSec is a New Jersey-based clinical-stage biotechnology company that researches and develops intratumoral immunotherapies for the treatment of cancer.
Read more